Scientists from the University of North Carolina have recently conducted computational modeling studies to predict the structure and immune escape ability of spike receptor-binding domain...
In a recent study published in Science*, researchers evaluated the ability of receptor-binding domain (RBD) antibodies to bind to and neutralize severe acute respiratory syndrome coronavirus-2...
In a recent study posted to the bioRxiv* preprint server, researchers evaluated the interactions of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron and...
Since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged, multiple variants of concern (VOCs) have arisen. These variants of concern show enhanced infectivity, immune evasion,...
In a recent paper posted to the bioRxiv* preprint server, researchers identified conserved sites in the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike protein using...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), since its emergence, has continuously evolved to evade host hostilities as well as increase transmission by raising new...
In a recent Viruses review, researchers discuss the evolution and mechanisms of mutations that have occurred in the spike (S) protein of the severe acute...
In a recent study posted to the bioRxiv* pre-print server, researchers investigated the potency of trimeric human nephrocystin SH3, TriSb92, a domain-derived antibody, against a conserved region...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), is a ribonucleic acid (RNA) virus that is prone to genetic...
A recent study published on the medRxiv* preprint server discusses the role of lateral flow device (LFD) testing in potentially improving coronavirus disease 2019 (COVID-19)...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) envelope (E) protein has a C-terminus with a PDZ binding motif (PBM) that targets PDZ (PSD-95/Dlg/ZO-1) domains....
A team of international scientists has recently isolated and characterized pan-coronavirus neutralizing antibodies from individuals with pre-existing immunity against severe acute respiratory syndrome coronavirus 2...
